3Sanders CC, Sanders WE Jr, Beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact [J]. Clin Infect Dis 1992,15(5):824-39.
4Lautenbach E, Patal JB, Bilker WB, et al. ESBLs producing Escherichia coli and Klebsiella pneu moniae factor for infection and impact of resistance on outcomes [J]. Clin Infect Dis, 2001,32(8):1162-1167.
5Schaad UB, Sander E, Wedgwood J, et al. Morphologic studies for skefetal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients[J]. Pediatr Infect Dis J, 1992,11:1047.
6Horan TC, Gaynes RP. Surveillance of nosocomial infections [M]//Mayhall CG. Hospital epidemiology and infection control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2004 : 1659-1702.
8McIntosh K. Community-acquired pneumonia in children [J]. N Engl J Med,2002,346(6):429-437.
9Yuan TM, Chen LH, Yu HM. Risk factors and outcomes for ventilator-associated pneumonia in neonatal intensive care unit patients [J]. J Perinat Med,2007,35(4): 334- 338.
10Melamed R, Greenberg D, Porat N, et al. Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit [J]. J Hosp Infect,2003,53(1): 31- 38.
7Snyder, GM, Thom KA, Furuno JP, et al. Detection of methicillin-resistant Staphylococcus aureus and vancomycin- resistant enterococci on the gowns and gloves of healthcare workers [J]. Infect Control Hosp Epidemiol, 2008, 29(7): 583-589.
8Hamdan-Partida A, Sainz-Espunes T, Bustos-Martinez J. Characterization and persistence of Staphylococcus aureus strains isolated from the anterior nares and throats of healthycarriers in a Mexican community [J]. J Clin Microbiol, 2010, 48(5): 1701-1705.
